ITIlya A. Tuchin

Ilya A. Tuchin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ilya A. Tuchin has a total of 167 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dilated Cardiomyopathy after Viral Infection in Young Patients: Case Reports

    by Ekaterina V. Balukova, Yuliya S. Belyaeva, Ilya A. Tuchin, Larisa G. Ermolaeva

    Dilated cardiomyopathy (DCM) is a severe myocardial disease characterized by marked dilation of the left ventricle or both ventricles and progressive heart failure. It is one of the leading indications for heart transplantation worldwide. The etiology of DCM is heterogeneous and includes both genetic predisposition and external factors, among which previous viral myocarditis plays a key role. However, establishing the exact etiology remains challenging, because verification of viral myocardial injury in routine clinical practice is associated with objective difficulties. This article presents two clinical cases of severe DCM in young patients after an acute respiratory viral infection. The development of end-stage heart failure refractory to medical therapy required advanced treatment modalities: heart transplantation was recommended for one patient, whereas the other underwent implantation of a cardiac contractility modulation (CCM) system. In addition, the disease course in the first patient was complicated by thromboembolism of segmental branches of the pulmonary arteries in both lungs. Maintaining a high level of clinical vigilance in patients presenting with nonspecific complaints such as dyspnea, weakness, pain, and chest discomfort after an acute respiratory viral infection is critically important, as early diagnosis and timely initiation of pathogenetic therapy for myocarditis may prevent structural myocardial changes and, consequently, irreversible dilation of the cardiac chambers.

  • Open Access

    Impact of vaccination status on the clinical course and outcomes of acute COVID-19 period: data from the international registry "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors" (AKTIV-4)

    by G Arutyunov, E Tarlovskaya, A Arutyunov, D Polyakov, Yu. Lopatin, A Chesnikova, L Balykova, A Vaisberg, A Galyavich, N Grigorieva, et al.

    Aim. To assess the effectiveness of vaccination against Omicron and Delta variants according to the international registry "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors" (AKTIV-4).Material and methods. The AKTIV-4 registry included men and women over 18 years of age with a diagnosis of coronavirus disease 2019 (COVID-19) (oropharyngeal and nasopharyngeal swabs, SARS-CoV-2 antibody titers, typical computed tomography performance), undergoing hospital treatment. A total of 3543 patients from 25 medical centers in 7 countries (the Russian Federation, the Republic of Armenia, the Republic of Belarus, the Republic of Kazakhstan, the Kyrgyz Republic, the Republic of Moldova, and the Republic of Uzbekistan) were included in the AKTIV-4 registry.Results. The clinical status of patients from the AKTIV-4 registry was more severe than in the AKTIV-1 and AKTIV-2 registries. Patients in the AKTIV-4 registry were older than patients in the AKTIV-1 registry. The inhospital mortality rate in patients in the AKTIV-4 registry was higher (8,41%, pConclusion. Vaccination, primarily with Sputnik V, is an independent predictor of survival in hospitalized COVID-19 patients and reduces the risk of death by 62% according to multivariate analysis.

  • Open Access

    Laboratory markers and radiological manifestations of the new coronavirus infection and their correlation with the severity of the disease: retrospective study

    by I. A. Tuchin, S. O. Mazurenko, N. T. Mirzoev, G. G. Kutelev, N. V. Golovkin, S. A. Parfenov, P. V. Petrova, A. I. Tuchina

    OBJECTIVE: Assess the connection between clinical, laboratory and radiological manifestations of the new coronavirus infection.MATERIALS AND METHODS: The study conducted a retrospective analysis of 100 patient medical histories, treated in Saint Petersburg State Budgetary Healthcare Institution «the Holy Martyr George Hospital» with confirmed diagnosis «Coronavirus infection COVID-19, the virus is identified». A statistical analysis of clinical laboratory values was carried out based on severity of COVID-19 course and infiltrative changes of lung tissue by computed tomography data. Statistics. Statistical analysis of the data was held using PC and set of software StatPlus 8.0. RESULTS: Depending on the nature of COVID-19 course, the comparison of clinical laboratory data among patients (average age 63,5 [19–98]) found that with increase in severity of the disease (mild – moderate − severe) there were changes in the following clinical laboratory values: erythrocyte sedimentation rate 15,4 ± 6,3 mm/h − 18,5 ± 13,5 mm/h – 31 ± 17 mm/h (positive correlation); lymphocyte level 1,49 ± 0,67 x 109 /l − 0,86 ± 1,45 x 109 /l − 0,68 ± 0,31 x 109 /l (negative correlation); C-reactive protein 8,4 ± 4,7 mg/l − 47,3 ± 18,7 mg/l − 148,7 ± 53,1 mg/l (positive correlation); ferritin 43,4 ± 24,8 µg/l − 743,9 ± 50,3 µg/l – 1425 ± 485,4 µg/l (positive correlation) and the degree of pulmonary tissue lesion according by computed tomography 0 % − 32 ± 13 % − 56 ± 11 % (positive correlation). DISCUSSION: In the course of this study it was found that mild course of COVID-19 is characterized by minor changes of laboratory values, compared to the group of severe and moderate course. There was a strong correlation between the level of COVID-19 severity and lymphocyte level (negative) as well as ferritin (positive) and the degree of infiltrative changes in lungs according on the computed tomography (positive). CONCLUSION: The revealed correlations do not allow a full planning of patient management tactics and to predict the course of COVID-19. Developed diagnostic and treatment algorithm should be based on clinical laboratory and instrumental assessment of the patient’s condition.